Back to today’s briefing

Story perspectives

Europe Faces Drug Crisis: Calls for Innovative Solutions

7/2/2025

50 9

Summary

Story summary

Europe is grappling with a pressing crisis in sourcing generic and biosimilar drugs, jeopardizing patient access to vital medications. Teva's Michal Nitka calls for innovative policies to bolster sustainable manufacturing in the face of soaring costs and regulatory challenges. The proposed Critical Medicines Act seeks to enhance supply, but lasting solutions demand stronger incentives and improved collaboration.

1 of 1

Story summary

Europe is grappling with a pressing crisis in sourcing generic and biosimilar drugs, jeopardizing patient access to vital medications. Teva's Michal Nitka calls for innovative policies to bolster sustainable manufacturing in the face of soaring costs and regulatory challenges. The proposed Critical Medicines Act seeks to enhance supply, but lasting solutions demand stronger incentives and improved collaboration.